ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,099.96
      1.02%
      US Tech 100
      17,244.80
      1.57%
      Dow Jones
      38,239.66
      0.40%
      Brent Oil
      88.165
      0.00%
      Bitcoin
      63,945.68
      0.84%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Avalon Pharmaceuticals (MM) (AVRX)

      7. Avalon Pharmaceuticals (MM) (AVRX) News

      AVRX

      Avalon (AVRX)

      Avalon Pharmaceuticals (MM)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:AVRX
      DateTimeSourceHeadlineSymbolCompany
      05/13/20093:39PMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      05/06/20094:48PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      05/06/20094:46PMEdgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      04/28/20095:05PMEdgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      04/28/20094:49PMBusiness WireAvalon Pharmaceuticals Announces Special Meeting DateNASDAQ:AVRXAvalon Pharmaceuticals (MM)
      04/07/20093:00PMBusiness WireAvalon Pharmaceuticals Receives Audit Opinion Containing Going Concern StatementNASDAQ:AVRXAvalon Pharmaceuticals (MM)
      04/02/200910:24AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      04/02/200910:22AMEdgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      03/31/20094:02PMEdgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      03/17/20095:07PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      03/17/20095:05PMEdgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      03/17/20093:00PMBusiness WireAvalon Pharmaceuticals Receives Staff Determination Regarding Nasdaq DelistingNASDAQ:AVRXAvalon Pharmaceuticals (MM)
      03/10/20094:07PMEdgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      02/17/20095:22PMEdgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      02/17/200911:35AMEdgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      02/13/20093:10PMEdgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      02/13/20092:29PMEdgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      02/11/20094:11PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      02/10/20095:04PMEdgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      01/30/20094:29PMEdgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      01/21/20094:19PMEdgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      01/14/200911:56AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      01/14/200911:54AMEdgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      12/22/20084:58PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      12/22/20084:56PMEdgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      12/22/20084:23PMBusiness WireAvalon Pharmaceuticals Receives Extension of Time to Comply with NASDAQ Deficiency NoticeNASDAQ:AVRXAvalon Pharmaceuticals (MM)
      11/25/20084:06PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      11/25/20082:18PMBusiness WireAvalon Pharmaceuticals Receives NASDAQ Deficiency NoticeNASDAQ:AVRXAvalon Pharmaceuticals (MM)
      11/13/200812:04PMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
      11/10/20081:39PMEdgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
       Showing the most relevant articles for your search:NASDAQ:AVRX